InsidersTradesSigma
팜젠사이언스 Stock: price and insider trades · South Korea · DART (FSS)
Track the 팜젠사이언스 share price and the full insider trade history of the company, a listed equity based in South Korea. Shares are quoted on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 팜젠사이언스 has logged 91 public disclosures. Market capitalisation: €75.4bn. The latest transaction was filed on 12 May 2026 (Purchase). Among the most active insiders: 한의상. The full history is free.
91
Insider Decl.
n/a
Thresholds
€2m
72 ops.
Buy Volume
n/a
3 ops.
Sell Volume
37Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 21,323 of 28,065 companies
33.8
score / 100
Value31
Quality37
FCF yld3.7%
Earn yld-165%
EV/EBITDA·
ROE0.1%
Gross mgn65%
Net mgn-67%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 12 May 2026
Declarations91 total
25 of 91 declarations
About 팜젠사이언스
Farmgen Science is a company in the health and pharmaceutical sector listed on the XKRX market. It specializes in the development of innovative pharmaceutical solutions.